glp 1 heart issues JCI GLP-1RA in Different HFpEF Phenotypes

Understanding how telehealth prescribing works alongside genetic predispositions and clinical markers helps patients make informed decisions about suitability and medication choice

The development of dual GIPRGLP1R coagonists that bind to either one or the other receptor (sequence-mixed dual agonists) has emerged as an innovative therapeutic strategy for obesity and type 2 diabetes

Retatrutide research overview: how LY3437943 triple agonist mechanism differs from dual and single GLP-1 receptor compounds

Water volumes, unit conversions, titration schedules, and storage guidelines for accurate dosing.

Given the promising results in pre-clinical models (even in the absence of T2D), a unique mechanism of action and multiple age-related reduced disease risks that have been reported with acarbose, support for clinical trials with acarbose focusing on aging-related outcomes and incorporating biological sex, age at treatment initiation, and T2D-dependence within the design is warranted.